These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Synthesis and antiplatelet effects of an isoxazole series of glycoprotein IIb/IIIa antagonists. Xue CB; Roderick J; Mousa S; Olson RE; DeGrado WF Bioorg Med Chem Lett; 1998 Dec; 8(24):3499-504. PubMed ID: 9934460 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists. Sielecki TM; Liu J; Mousa SA; Racanelli AL; Hausner EA; Wexler RR; Olson RE Bioorg Med Chem Lett; 2001 Aug; 11(16):2201-4. PubMed ID: 11514170 [TBL] [Abstract][Full Text] [Related]
10. Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonists. Mehrotra MM; Heath JA; Smyth MS; Pandey A; Rose JW; Seroogy JM; Volkots DL; Nannizzi-Alaimo L; Park GL; Lambing JL; Hollenbach SJ; Scarborough RM J Med Chem; 2004 Apr; 47(8):2037-61. PubMed ID: 15056002 [TBL] [Abstract][Full Text] [Related]
11. Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists. Sielecki TM; Wityak J; Liu J; Mousa SA; Thoolen M; Wexler RR; Olson RE Bioorg Med Chem Lett; 2000 Mar; 10(5):449-52. PubMed ID: 10743945 [TBL] [Abstract][Full Text] [Related]
12. Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines. Confalone PN; Jin F; Mousa SA Bioorg Med Chem Lett; 1999 Jan; 9(1):55-8. PubMed ID: 9990456 [TBL] [Abstract][Full Text] [Related]
13. Effect of salt form on chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms. Badawy SI Int J Pharm; 2001 Jul; 223(1-2):81-7. PubMed ID: 11451634 [TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor. Mutlib AE; Diamond S; Shockcor J; Way R; Nemeth G; Gan L; Christ DD Xenobiotica; 2000 Nov; 30(11):1091-110. PubMed ID: 11197070 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of cis and trans isomers of an isoxazoline ring-hydroxylated metabolite of roxifiban, a platelet glycoprotein IIb/IIIa receptor antagonist. Batt DG; Houghton GC; Daneker WF; Jadhav PK J Org Chem; 2000 Nov; 65(23):8100-4. PubMed ID: 11073629 [No Abstract] [Full Text] [Related]
16. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate. Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic analysis of TS-943, a selective non-peptide platelet glycoprotein-IIb/IIIa (GPIIb/IIIa) receptor antagonist, using a nonlinear mixed effect model in dogs. Furuya A; Nozawa M; Gotoh J; Jingu S; Akimoto M; Higuchi S; Suwa T; Ogata H J Pharm Pharmacol; 2002 Jul; 54(7):921-7. PubMed ID: 12162710 [TBL] [Abstract][Full Text] [Related]
18. Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists. Sall DJ; Arfsten AE; Bastian JA; Denney ML; Harms CS; McCowan JR; Morin JM; Rose JW; Scarborough RM; Smyth MS; Um SL; Utterback BG; Vasileff RT; Wikel JH; Wyss VL; Jakubowski JA J Med Chem; 1997 Aug; 40(18):2843-57. PubMed ID: 9288166 [TBL] [Abstract][Full Text] [Related]
19. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Storey RF; May JA; Wilcox RG; Heptinstall S Thromb Haemost; 1999 Oct; 82(4):1307-11. PubMed ID: 10544919 [TBL] [Abstract][Full Text] [Related]